Aliases & Classifications for Peripheral Vertigo

MalaCards integrated aliases for Peripheral Vertigo:

Name: Peripheral Vertigo 12 15
Vertigo, Peripheral 73

Classifications:



External Ids:

Disease Ontology 12 DOID:9847
ICD9CM 35 386.1 386.19

Summaries for Peripheral Vertigo

MalaCards based summary : Peripheral Vertigo, also known as vertigo, peripheral, is related to malignant otitis externa and cerebral falx meningioma, and has symptoms including vertigo An important gene associated with Peripheral Vertigo is COCH (Cochlin), and among its related pathways/superpathways are Collagen chain trimerization and Formation of Fibrin Clot (Clotting Cascade). The drugs Piracetam and Histamine have been mentioned in the context of this disorder. Affiliated tissues include neutrophil, and related phenotypes are homeostasis/metabolism and nervous system

Related Diseases for Peripheral Vertigo

Diseases related to Peripheral Vertigo via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 156)
# Related Disease Score Top Affiliating Genes
1 malignant otitis externa 10.9 CRP F2
2 cerebral falx meningioma 10.9 F2 F3
3 chronic thromboembolic pulmonary hypertension 10.9 CRP F2
4 abdominal tuberculosis 10.9 CRP F2
5 paracetamol poisoning 10.9 F2 F5
6 qualitative platelet defect 10.9 F2 F3
7 ischemic neuropathy 10.9 CRP F2
8 may-thurner syndrome 10.9 APOH F5
9 splenic infarction 10.9 APOH F2
10 acquired angioedema 10.9 CRP F5
11 von willebrand disease, type 1 10.9 F2 F3
12 acquired hemophilia a 10.8 F3 F5
13 acanthamoeba keratitis 10.8 APOH F5
14 blood protein disease 10.8 F2 SERPINC1
15 acquired hemophilia 10.8 F3 F5
16 hemoglobin e disease 10.8 F2 F5
17 alpha-2-plasmin inhibitor deficiency 10.8 F2 SERPINC1
18 femoral neuropathy 10.8 F2 F3
19 heparin-induced thrombocytopenia 10.8 F3 SERPINC1
20 pregnancy loss, recurrent 1 10.8 APOH F5
21 alcohol-related birth defect 10.8 F2 F3
22 papilledema 10.8 APOH F2
23 hantavirus pulmonary syndrome 10.8 F2 F3
24 anterior cranial fossa meningioma 10.8 F2 F3
25 mediastinitis 10.8 CRP F5
26 sticky platelet syndrome 10.8 F5 SERPINC1
27 japanese spotted fever 10.8 CRP SERPINC1
28 splenic disease 10.8 F2 F3
29 cryptogenic cirrhosis 10.7 F2 F5
30 anterior spinal artery syndrome 10.7 F2 SERPINC1
31 factor viii deficiency 10.7 F2 F5
32 subendocardial myocardial infarction 10.7 F2 SERPINC1
33 porencephaly 10.7 F2 F5
34 buerger disease 10.7 APOH F2
35 endocardium disease 10.7 CRP F2 F3
36 multicentric castleman disease 10.7 CRP F3
37 esophageal varix 10.7 F2 SERPINC1
38 infective endocarditis 10.7 APOH CRP F2
39 arteritic anterior ischemic optic neuropathy 10.6 CRP F2 F5
40 livedoid vasculopathy 10.6 APOH F2 F5
41 intestinal impaction 10.6 F2 F3 SERPINC1
42 fournier gangrene 10.6 F2 F3 SERPINC1
43 leech infestation 10.6 F2 F3 SERPINC1
44 giant hemangioma 10.6 F2 F3 SERPINC1
45 intracranial embolism 10.6 F2 F3 SERPINC1
46 severe hemophilia a 10.6 F2 F3 F5
47 marantic endocarditis 10.6 F2 F3 SERPINC1
48 thrombasthenia 10.6 F2 F3 F5
49 purpura fulminans 10.6 F2 F3 SERPINC1
50 korean hemorrhagic fever 10.6 F2 F3 SERPINC1

Comorbidity relations with Peripheral Vertigo via Phenotypic Disease Network (PDN):


Hypertension, Essential Ischemic Heart Disease
Labyrinthitis

Graphical network of the top 20 diseases related to Peripheral Vertigo:



Diseases related to Peripheral Vertigo

Symptoms & Phenotypes for Peripheral Vertigo

UMLS symptoms related to Peripheral Vertigo:


vertigo

MGI Mouse Phenotypes related to Peripheral Vertigo:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.7 F3 F5 KCNE3 RTEL1 SERPINC1 SLC26A4
2 nervous system MP:0003631 9.28 F2 F3 F5 KCNE3 RTEL1 SERPINC1

Drugs & Therapeutics for Peripheral Vertigo

Drugs for Peripheral Vertigo (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Piracetam Approved, Investigational Phase 4 7491-74-9
2
Histamine Approved, Investigational Phase 4,Phase 3 75614-87-8, 51-45-6 774
3
Dimenhydrinate Approved Phase 4 523-87-5 441281
4
Histamine Phosphate Phase 4,Phase 3 51-74-1 65513
5 Gastrointestinal Agents Phase 4,Phase 3
6 Neurotransmitter Agents Phase 4,Phase 3
7 Histamine Antagonists Phase 4,Phase 3
8 Histamine H1 Antagonists Phase 4,Phase 3
9 Peripheral Nervous System Agents Phase 4,Phase 3
10 Antiemetics Phase 4,Phase 3
11 Autonomic Agents Phase 4,Phase 3
12
Lorazepam Approved Phase 3 846-49-1 3958
13
Diphenhydramine Approved, Investigational Phase 3 147-24-0, 58-73-1 3100
14
Promethazine Approved, Investigational Phase 3 60-87-7 4927
15 Central Nervous System Depressants Phase 3
16 GABA Agents Phase 3
17 GABA Modulators Phase 3
18 Anesthetics Phase 3
19 Dermatologic Agents Phase 3
20 Anesthetics, Local Phase 3
21 Tranquilizing Agents Phase 3
22 Anti-Allergic Agents Phase 3
23 Anti-Anxiety Agents Phase 3
24 Hypnotics and Sedatives Phase 3
25 Anticonvulsants Phase 3
26 Antipruritics Phase 3
27 Psychotropic Drugs Phase 3
28
Betahistine Approved, Investigational 5638-76-6 2366
29 Vasodilator Agents

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo Completed NCT01890538 Phase 4 Administration of 100 mg dimenhydrinate intravenous;2 g piracetam intravenous
2 Promethazine vs. Lorazepam for Treatment of Vertigo Completed NCT01827293 Phase 3 Promethazine;Lorazepam
3 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vestibular Vertigo in Routine Practice Completed NCT01759251
4 Diagnosis Of Vertigo With New Imaging Completed NCT00593216
5 Effects of a Vestibular Rehabilitation Maneuver Completed NCT01080430 Not Applicable

Search NIH Clinical Center for Peripheral Vertigo

Genetic Tests for Peripheral Vertigo

Anatomical Context for Peripheral Vertigo

MalaCards organs/tissues related to Peripheral Vertigo:

41
Neutrophil

Publications for Peripheral Vertigo

Articles related to Peripheral Vertigo:

(show all 48)
# Title Authors Year
1
Author response: Clinical Reasoning: Labyrinthine hemorrhage: An unusual etiology for peripheral vertigo. ( 29335312 )
2018
2
Editors' note: Clinical Reasoning: Labyrinthine hemorrhage: An unusual etiology for peripheral vertigo. ( 29335310 )
2018
3
Reader response: Clinical Reasoning: Labyrinthine hemorrhage: An unusual etiology for peripheral vertigo. ( 29335311 )
2018
4
Decompensated labyrinthine weakness presenting as de novo peripheral vertigo: a discrete clinical entity? ( 29343311 )
2018
5
Analysis of Risk Factors in Patients With Peripheral Vertigo or Central Vertigo. ( 29722738 )
2018
6
New Onset Focal Stabbing Headache Associated With Peripheral Vertigo: A Case Report. ( 29034450 )
2018
7
Clinical Reasoning: Labyrinthine hemorrhage: An unusual etiology for peripheral vertigo. ( 28069982 )
2017
8
The impact of opioid medications on subsequent fractures in discharged emergency department patients with peripheral vertigo. ( 28631577 )
2017
9
A Comparison of the Effects and Side Effects of Oral Betahistine with Injectable Promethazine in the Treatment of Acute Peripheral Vertigo in Emergency. ( 29163732 )
2017
10
Effect of a vestibular rehabilitation protocol to improve the health-related quality of life and postural balance in patients with peripheral vertigo. ( 27676762 )
2016
11
THE USEFULNESS OF MONITORING THE NEUTROPHIL TO LYMPHOCYTE RATIO IN PATIENTS WITH PERIPHERAL VERTIGO. ( 27661276 )
2016
12
Anxiety and depression among patients with different types of vestibular peripheral vertigo. ( 25654382 )
2015
13
Use of betahistine in the treatment of peripheral vertigo. ( 26245698 )
2015
14
Associations between peripheral vertigo and gastroesophageal reflux disease. ( 26115947 )
2015
15
Histamine Antagonists for Treatment of Peripheral Vertigo: A Meta-Analysis. ( 26381004 )
2015
16
Outcomes among patients discharged from the emergency department with a diagnosis of peripheral vertigo. ( 26385410 )
2015
17
Neutrophil-to-lymphocyte ratio in patients with peripheral vertigo: A prospective controlled clinical study. ( 25219290 )
2014
18
Intravenous promethazine versus lorazepam for the treatment of peripheral vertigo in the emergency department: A double blind, randomized clinical trial of efficacy and safety. ( 24594499 )
2014
19
Evaluation of the effect of nimodipine o.d. (extended release) vs nimodipine t.i.d. in the treatment of peripheral vertigo. ( 23808594 )
2013
20
Response to: "Cerebellar infarctions mimicking acute peripheral vertigo," from Yeo et al. ( 23633501 )
2013
21
Letter to the editor on "Cerebellar infarctions mimicking acute peripheral vertigo: how to avoid misdiagnosis?". ( 23633500 )
2013
22
Cerebellar infarctions mimicking acute peripheral vertigo: how to avoid misdiagnosis? ( 23307911 )
2013
23
Comparison of the effectiveness of intravenous piracetam and intravenous dimenhydrinate in the treatment of acute peripheral vertigo in the emergency department. ( 24276103 )
2013
24
An easy diagnostic tool distinguishing lateral medullary infarction from peripheral vertigo. ( 21855212 )
2012
25
Medullary infarction after vertebral artery dissection presenting as acute peripheral vertigo. ( 21307810 )
2011
26
Sonographic examination of epiaortic vessels in patients with peripheral vertigo. ( 23396499 )
2010
27
Stiff-person syndrome with acute recurrent peripheral vertigo: possible evidence of gamma aminobutyric acid as a neurotransmitter in the vestibular periphery. ( 17666138 )
2008
28
Is surgical vestibular ablation necessary in disabling peripheral vertigo? ( 23120494 )
2008
29
Role of C-reactive protein, D-dimer, and fibrinogen levels in the differential diagnosis of central and peripheral vertigo. ( 18029334 )
2007
30
Intracranial vertebral artery dissection mimicking acute peripheral vertigo. ( 16428195 )
2006
31
Surgical treatment of peripheral vertigo and vertiginous diseases. ( 15637415 )
2005
32
Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo. ( 15474112 )
2004
33
Relevance of plasma D-dimer measurement in patients with acute peripheral vertigo. ( 12818056 )
2003
34
Acute peripheral vertigo: involvement of the hemostatic system. ( 15106288 )
2003
35
Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral vertigo in the emergency department: a randomized clinical trial. ( 12045085 )
2002
36
New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study. ( 11981396 )
2002
37
A study on peripheral vertigo in a Kolkata based hospital. ( 23119868 )
2002
38
Posterior fossa vestibular nerve section for the management of peripheral vertigo. ( 10392296 )
1999
39
Droperidol for the treatment of acute peripheral vertigo. ( 9928721 )
1999
40
3D analysis of nystagmus in peripheral vertigo. ( 9105433 )
1997
41
Overall view and rationale for surgical alternatives for incapacitating peripheral vertigo. ( 8022608 )
1994
42
Surgical treatment of incapacitating peripheral vertigo. Criteria for the evaluation of surgical results. ( 8022609 )
1994
43
Transdermal scopolamine for peripheral vertigo (a double-blind study). ( 3894551 )
1985
44
Peripheral vertigo. ( 3979333 )
1985
45
The causes of peripheral vertigo. ( 6499708 )
1984
46
Peripheral vertigo. ( 6499706 )
1984
47
Complications of treatment of peripheral vertigo. ( 6149924 )
1984
48
Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc versus placebo. ( 7019369 )
1981

Variations for Peripheral Vertigo

Expression for Peripheral Vertigo

Search GEO for disease gene expression data for Peripheral Vertigo.

Pathways for Peripheral Vertigo

GO Terms for Peripheral Vertigo

Cellular components related to Peripheral Vertigo according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.76 APOH AQP2 COCH CRP F2 F3
2 extracellular space GO:0005615 9.56 APOH AVP CRLF1 CRP F2 F3
3 extracellular region GO:0005576 9.32 APOH AVP COCH CRLF1 CRP F2

Biological processes related to Peripheral Vertigo according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 blood coagulation GO:0007596 9.46 F2 F3 F5 SERPINC1
2 blood coagulation, intrinsic pathway GO:0007597 9.4 APOH F2
3 water transport GO:0006833 9.37 AQP2 AVP
4 positive regulation of blood coagulation GO:0030194 9.32 APOH F2
5 negative regulation of fibrinolysis GO:0051918 9.26 APOH F2
6 regulation of blood coagulation GO:0030193 9.13 APOH F2 SERPINC1
7 hemostasis GO:0007599 8.92 F2 F3 F5 SERPINC1

Molecular functions related to Peripheral Vertigo according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 heparin binding GO:0008201 8.8 APOH F2 SERPINC1

Sources for Peripheral Vertigo

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....